# K980668: CMS Blizzard 700 Series Models 730, 740,750,760,770,780 & 790

- Pathway: 510(k) (Traditional)
- Applicant: Cryomedical Sciences, Inc.
- Decided: Jul 17, 1998 after 147 days
- Product code: GEH (Unit, Cryosurgical, Accessories)
- Device class: 2
- Regulation: 21 CFR 878.4350
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
32 later devices descend from it; 1 cites it directly.
0 of 33 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) ENDOcare’s CRYOcare System: named in the summary without a submission number
- (no number) CMS AccuProbe® Systems: named in the summary without a submission number
- (no number) CMS Cryo-lite™ System: named in the summary without a submission number

## Most influential descendants
- K011988: Surgical Lightstic 180, Model 180 L, Model 180 C (2001), 31 descendants of its own
- K013901: Malleable Surgical Lightstic 180, Model 180 (1CM-9CM) (2001), 30 descendants of its own
- K022894: Epicor Medical Ablation System (2004), 23 descendants of its own
- K040641: Ultracinch Ablation Device, Ultracinch Accessory Pack, Models UC-8, UC-9, UC-10, UC-11, UC-12, UC-13, UC-14, UC-Acc-1 (2004), 22 descendants of its own
- K043579: Atricure Bipolar System (2007), 18 descendants of its own

## Indications for use
Depending on the cryogen used, the following are indications for use: Liquid Nitrogen: For use as a cryosurgical tool for destruction of unwanted tissue in the fields of dermatology, general surgery, neurosurgery, thoracic surgery, urology, proctology, oncology, gynecology and ENT. May be used to ablate prostatic tissue. May be used for the ablation of prostatic tissue in cases of prosfofe cancer and benign prostatic hyperplasia. May be used for ablation of cancerous or malignant tissue. May be used for ablation of benign tumors. May be used for palliative intervention. May be used for ablation or freezing of skin cancers and other cutaneous disorders. May be used for the ablation of malignant neoplasia or benign dysplasia of the female genitalia. May be used for ablation of leukoplakia of mouth, angiomas, sebaceous hyperplasia, basal cell tumors of the eyelid and canthus area, ulcerated basal cell tumors, dermatofioromas, small hemangiomas, mucocele cysts, multiple warts, plantar warts, hemorrhoids, and fissures, peri-anal condylomata, pilonidal cysts, actinic and seborrheic keratoses, cavernous hemangiomas, recurrent cancerous lesions. May be used for the destruction of warts or lesions, May be used for the palliation of tumors of the oral cavity, rectum, and skin. May be used for ablation of arrhythmic cardiac tissue. May be used for the ablation of benign or malignant growths of the anus and rectum. May be used for the ablation of hemorrhoids. Nitrous Oxide: For use as a tool in the destruction of unwanted tissue in the fields of dermatology, gynecology, general surgery, urology, and veterinary medicine. Carbon Dioxide: For used as a tool in the destruction of unwanted tissue in the fields of dermatology, gynecology, and general surgery. Argon and Krypton: For use as a cryosurgical tool in general surgery, dermatology, neurology, thoracic surgery, ENT, gynecology, oncology, proctology, and urology for the ablation of tissue including liver metastases, skin Jlesions, warts and prostate tissue.

Source page: https://510kreport.com/device/K980668
Methodology: https://510kreport.com/methodology